Community/Retail

National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to Senate passage of S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, professor and department chair for Pharmacy Practice, University of Mississippi School of Pharmacy, offers advice for how pharmacists can approach the delicate subject of weight-loss with patients.

Pharmacy Times' March Madness bracket combines sports and pharmacy.

Ever since the human papillomavirus vaccine hit the market 6 years ago, the prevalence of HPV has markedly decreased among women aged 14 to 24 years.

Pharmacists should double-check patients self-reporting allergies to ensure that they're taking accurate and appropriate treatment.

The FDA has approved obiltoxaximab (Anthim) injection to treat inhalational anthrax in combination with appropriate antibacterial medications.

The Meijer LPGA Classic for Simply Give has announced a three-day grand tasting event that Meijer will host in conjunction with the LPGA tournament week June 14-19.

The FDA has expanded the use of crizotinib, making it the first and only FDA-approved treatment for individuals with advanced non-small cell lung cancer whose tumors have an ROS-1 gene alteration.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses what pharmacists should know about CAT and mMRC scores.

Jeffrey Goad, PharmD, MPH, FAPhA, discusses some of the recent changes to immunization recommendations and schedules for US children and adults that pharmacists should know.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how to classify symptom severity, assess control, and monitor therapy for asthma and chronic obstructive pulmonary disorder.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses the role pharmacists can play in helping physicians interpret urine screens.

Dennis Williams, PharmD, FAPhA, discusses the current management strategies for allergic rhinitis.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses the problems related to inappropriate equianalgesic conversions when performing opioid rotations.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses the current guidelines pharmacists should refer to when selecting respiratory medication inhalers and managing asthma and chronic obstructive pulmonary disorder.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Possible side effects for multiple sclerosis medications can range from mild to life-threatening.

The FDA has approved Spectrum Pharmaceuticals' melphalan for 2 new indications for patients with multiple myeloma.

Daniel T. Abazia, PharmD, BCPS, discusses some of the non-pharmacologic treatment options that pharmacists can recommend to patients experiencing opioid-induced constipation.

Patients diagnosed with bipolar disorder are at very high risk for medication nonadherence.

Amid changes in the health care landscape, there is little doubt that technicians are taking on more prominent roles within the pharmacy team.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses and debunks the myths and hysteria surrounding the use of opioid therapy in treating non-cancer pain.

Greater than 10% of referrals to respiratory specialists are for chronic cough, given the condition's persistent, refractory nature.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses strategies pharmacists can employ to enhance the safe use of chronic opioid therapy.

The FDA is reviewing Amgen's supplemental biologics license application for the expanded use of etanercept to treat pediatric patients with chronic severe plaque psoriasis.

Most patients understand very little about the amount of social work pharmacists perform on a daily basis.

One of the most under-recognized and under-addressed barriers to safe and effective care is low vision.

Daniel T. Abazia, PharmD, BCPS, outlines some of the factors that might contribute to a patient's propensity to experience opioid-induced constipation.

Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the effects of expanded naloxone access.

The American Pharmacists Association House of Delegates voted to adopt new policy on the labeling and measurement of oral liquid medications at the recently completed APhA Annual Meeting in Baltimore Maryland.